Hydrothermal synthesis of silver vanadate nanoparticles, antimicrobial and anti-inflammatory potentials, cytotoxicity and interference on the activity of antimicrobial drugs
Abstract
Bacterial resistance to antimicrobial drugs represents a critical threat to global health, compromising the efficacy of standard therapies. In this study, we evaluated the antimicrobial properties of silver vanadate microrods (SVMs) against clinical isolates of Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa. SVMs were active against all tested isolates, with MIC values of 128 µg/mL for S. aureus and 256 µg/mL for Gram-negative species. Notably, checkerboard assays revealed synergistic interactions with azithromycin, clindamycin, and sulfamethoxazole (FICi 0.093-0.125), indicating that SVM might potentiate the activity of antimicrobial drugs. The MBC/MIC ratio classified SVM as bactericidal against Gram-negative isolates and bacteriostatic against S. aureus. Scanning electron microscopy suggested a membrane disruption mechanism by a direct nanoparticle-bacteria interaction. SVM also exhibited anti-inflammatory activity comparable to tenoxicam in vitro. SVM presented cytotoxicity to BGM cells at 3.13 µg/mL (CC50). Our findings suggest that SVM is a promising candidate for combination therapy, warranting further investigation with surface-functionalized formulations to improve its selectivity.
Keywords
Supporting Institution
Project Number
Ethical Statement
Thanks
References
- Dias-Souza, M.V., Perpétuo, A.A., dos Santos, G.S., Machado, L.F.C. and dos Santos, R.M., “Natural products in drug discovery: Meeting the urgency for new antimicrobials for human and veterinary use”, AIMS Molecular Science, 10: 11-21, (2023). DOI: https://doi.org/10.3934/molsci.2023002
- Huemer, M., Mairpady Shambat, S., Brugger, S.D. and Zinkernagel, A.S., “Antibiotic resistance and persistence-Implications for human health and treatment perspectives”, EMBO Reports, 21(12): e51034, (2020). DOI: https://doi.org/10.15252/embr.202051034
- Giulieri, S.G., Leroi, M., Daniel, D., Chean, R., Bond, K., Walker, H., Holmes, N.E., Mothobi, N., Alexander, A., Jenney, A., Beckett, C., Mahony, A., Stevens, K., Sherry, N.L., and Howden, B.P., “A multi-hospital, clinician-initiated bacterial genomics programme to investigate treatment failure in severe Staphylococcus aureus infections”, Nature Communications, 16: 4869, (2025). DOI: https://doi.org/10.1038/s41467-025-60045-4
- World Bank Group, “Antimicrobial resistance (AMR)”, World Bank Report, Washington, (2025).
- Lin, D., Du, S., Zhao, Z., Zhang, T., Wang, L., Zhang, Q., Zhou, S.Y., Graham, D.W., Tissue, D.T., Zhu, D., Zhu, Y.G., Penuelas, J., and Reich, P.B., “Climate warming fuels the global antibiotic resistome by altering soil bacterial traits”, Nature Ecology & Evolution, (2025). DOI: https://doi.org/10.1038/s41559-025-02740-5
- GBD 2019 Antimicrobial Resistance Collaborators, “Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019”, Lancet, 400(10369): 2221–2248, (2022). DOI: https://doi.org/10.1016/S0140-6736(22)02185-7
- Tang, K.W.K., Millar, B.C. and Moore, J.E., “Antimicrobial Resistance (AMR)”, British Journal of Biomedical Science, 80: 11387, (2023). DOI: https://doi.org/10.3389/bjbs.2023.11387
- Arulkumaran, N., Routledge, M., Schlebusch, S., Lipman, J. and Conway Morris, A., “Antimicrobial-associated harm in critical care: A narrative review”, Intensive Care Medicine, 46(2): 225–235, (2020). DOI: https://doi.org/10.1007/s00134-020-05929-3
Details
Primary Language
English
Subjects
Nanobiotechnology, Infectious Agents
Journal Section
Research Article
Authors
Early Pub Date
August 11, 2026
Publication Date
-
Submission Date
January 31, 2026
Acceptance Date
July 22, 2026
Published in Issue
Year 2026 Number: Advanced Online Publication